Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,994 | 6,608 | 1,115 | 2,217 | 1,122 |
| Receivables | 36 | 154 | 75 | 80 | 71 |
| Inventories | 384 | 398 | 413 | 417 | 437 |
| Other current assets | 38 | 37 | 84 | 38 | 81 |
| TOTAL | $5,690 | $7,403 | $1,688 | $2,770 | $1,711 |
| Non-Current Assets | |||||
| PPE Net | 16 | 17 | 18 | 19 | 20 |
| Other Non-Current Assets | 157 | 171 | 199 | 130 | 140 |
| TOTAL | $173 | $188 | $218 | $148 | $160 |
| Total Assets | $5,862 | $7,591 | $1,905 | $2,918 | $1,871 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,323 | 2,691 | 2,623 | 1,925 | 1,655 |
| TOTAL | $2,337 | $2,705 | $2,637 | $1,925 | $1,655 |
| Non-Current Liabilities | |||||
| Long Term Debt | 42 | 46 | 50 | N/A | N/A |
| TOTAL | $42 | $46 | $50 | $N/A | $N/A |
| Total Liabilities | $2,379 | $2,751 | $2,687 | $1,925 | $1,655 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,212 | 1,210 | 913 | 913 | 877 |
| Common Shares | 12 | 12 | 9 | 9 | 9 |
| Retained earnings | -22,485 | -20,860 | -19,492 | -17,588 | -16,222 |
| Other shareholders' equity | 0 | 0 | 0 | -130 | 0 |
| TOTAL | $3,483 | $4,840 | $-782 | $993 | $216 |
| Total Liabilities And Equity | $5,862 | $7,591 | $1,905 | $2,918 | $1,871 |